About Cook Pharmica
Cook Pharmica is a Healthcare company based in Bloomington (United States) founded in 2004, and was acquired by Catalent in October 2017. Contract development and manufacturing services are provided to biopharmaceutical firms. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation. Its competitors include Exela Pharma, August Bioservices and ApiJect; 3 of its 3 listed competitors have raised funding.
Company details
Cook Pharmica was founded in 2004 in Bloomington, United States, and is operated as a contract development and manufacturing organization in the biopharmaceutical sector. A one-source, one-location model is employed for services including development, clinical and commercial cell culture manufacturing, formulation, parenteral product manufacturing, and secondary packaging. Both clinical and commercial production are supported. The company functions as a subsidiary of Cook Group.
- Headquarters Bloomington, United States
- Stage Acquired
- SectorsHealthcare
- Website cookpharmica.com
- Social LinkedIn Facebook
- Acquired by Catalent (Oct 2017)
Investors in Cook Pharmica
Cook Pharmica has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Catalent.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
CDMO offering drug and biologics development services | 2007 | catalent.com | Somerset, United States |
Investor details for Cook Pharmica
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Cook Pharmica
2 dated milestones of Cook Pharmica across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Cook Pharmica is founded.
- Exit Acquired by Catalent.
Competitors of Cook Pharmica
Cook Pharmica has 3 listed competitors in our database, 3 of them funded. They include Exela Pharma, August Bioservices and ApiJect.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| exelapharma.com | 2005 | Lenoir, United States | $7.09M | 247 | Sterile injectable pharmaceuticals are manufactured alongside CDMO services. | |
| augustbio.com | 2017 | Nashville, United States | $88.6M | 86 | Diversified research services for clinical solutions are offered. | |
| apiject.com | 2015 | Stamford, United States | $111M | Medicine injectors are manufactured by ApiJect for medical applications. |
Detailed competitors of Cook Pharmica
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cook Pharmica
Websites that share an audience with Cook Pharmica (cookpharmica.com).
Websites whose visitors overlap most with Cook Pharmica. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
jin-esact.org | jin-esact.org | 100% | – | ||
| catalent.com | 98% | 116.7K | #338,870 | View details | |
| baxterbiopharmasolutions.com | 97% | 680.7K | View details | ||
| cookgroup.com | 77% | #5,246,102 | View details | ||
capitalmedica.over-blog.com | capitalmedica.over-blog.com | 59% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for Cook Pharmica
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Cook Pharmica (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cook Pharmica
Cook Pharmica was founded in 2004.
Cook Pharmica is headquartered in Bloomington, United States. It is registered at Bloomington, Indiana, United States.
Cook Pharmica was founded in 2004 in Bloomington, United States, and is operated as a contract development and manufacturing organization in the biopharmaceutical sector. A one-source, one-location model is employed for services including development, clinical and commercial cell culture manufacturing, formulation, parenteral product manufacturing, and secondary packaging. Both clinical and commercial production are supported. The company functions as a subsidiary of Cook Group.
Cook Pharmica's top competitors include Exela Pharma, August Bioservices and ApiJect.
Cook Pharmica has 1 investor. Key investors include Catalent.
Yes. Cook Pharmica was acquired by Catalent in October 2017.